ESC 365 - Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension (PH): impact of the new definition of PH

ESC Premium Access

Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension (PH): impact of the new definition of PH

Session: Poster Session 4 - Pulmonary arterial hypertension - Treatments

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor A. Marra (Naples, IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Associate Professor Alberto Maria Marra

University of Naples Federico II, Naples (Italy)

0 follower

10 more presentations in this session

Efficacy of the novel thromboxane receptor antagonist NTP42 alone, or in combination with Sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension

Speaker: Professor T. Kinsella (Dublin, IE)

Selexipag dosing and titration in the first 500 patients enrolled in SPHERE (SelexiPag: tHe UsErs dRug rEgistry)

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Effects of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension

Speaker: Doctor T. Sasiprapha (Bangkok, TH)

Electroanatomical mapping of right atrium in patients with pulmonary hypertension

Speaker: Doctor Z. Fingrova (Prague, CZ)

Patient characteristics and treatment patterns in the multicentre, retrospective chart review of first-time Opsumit (macitentan) users in the United States (OrPHeUS)

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Access the full session

Poster Session 4 - Pulmonary arterial hypertension - Treatments

Speakers: Associate Professor A. Marra, Professor T. Kinsella, Professor V. McLaughlin, Doctor T. Sasiprapha, Doctor Z. Fingrova...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources